Transgenic mice expressing the R1441C mutant LRRK2 can partially replicate the phenotype of PD, such as decreased dopamine levels and abnormalities in the nigrostriatal projection (Li Y. et al., 2009). This evidence concerns the gene LRRK2 and Parkinson disease.